Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 9, 2019 (7 years ago)

PRE-TAT (lidocaine)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Cause type: Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection. All microbial contamination recalls.

What was recalled

PRE-TAT (lidocaine) 3 in 1 Pre Tattoo Prep With Lidocaine Cream, 4%, packaged in a) 1 OZ (NDC 69804-002-05), b) 2 OZ (NDC 69804-002-02), and c) 4 OZ (NDC 69804-002-03) jars, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.

Affected NDCs 69804-0002-02 69804-0002-03 69804-0002-05

Compare with the code on your package — it is the most precise check available.

Drug: Lidocaine

Recalling firm
Ridge Properties, LLC
NDC code
69804-002-05
Origin
OR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1856-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Lidocaine recalls

See all
Class II · Moderate risk

Lidocaine Ointment USP

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Ongoing Wrong potency / content Sun Pharma /Taro D-0848-2026
Class III · Low risk

Lidolog Kit

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Ongoing Labeling / mix-up Asclemed USA Inc. D-0713-2026

Other recalls by Ridge Properties, LLC

All 2019 recalls
Class II · Moderate risk

Soothing Sore Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-077-14 D-1861-2019
Class II · Moderate risk

Soothing Sore Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-074-05 D-1860-2019
Class II · Moderate risk

Superior Pain & Itch Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-073-14 D-1859-2019
Class II · Moderate risk

Superior Pain & Itch Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-070-05 D-1858-2019